Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Aerosolized immunogenic compositions that may prove useful for vaccination against respiratory infections and may provide a platform for generating mucosal antibody responses against other pathogens. More
A variety of new toxoids useful as botulinum vaccine antigens, for BAT or BIG production, or for development of tests to evaluate antigenicity of botulinum vaccines More
Methods and compositions for making and using functionalized sugars More
Use of Shewanella CPS conjugates as a component of an anthrax vaccine More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Apr 2011 - 104 pages - $3,800
Nov 2011 - 7 pages - $3,835
Jan 2008 - 180 pages - $3,500
Mar 2011 - 32 pages - $250
Dec 2010 - 37 pages - $5,700
Jun 2006 - 1458 pages - $2,495
Dec 2010 - 58 pages - $5,700
Mar 2009 - 104 pages - $5,700
Oct 2009 - 17 pages - $500
Your selection
Browse By
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us